{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:22:55Z","timestamp":1793395375742,"version":"4.5.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>One of the most common extraintestinal manifestations of inflammatory bowel disease is iron deficiency anemia. It is often an untreated condition that significantly impairs patients' quality of life and elevates mortality and morbidity. Although it is often accompanied by mild symptoms (e.g., fatigue, lethargy), it can provoke severe health conditions, such as dyspnea, palpitation, angina, and mental disorders, and increases hospitalization and mortality rate as well. As anemia develops through several pathomechanisms, such as occult bleeding, chronic inflammation, and medicines (e.g., methotrexate), treating anemia effectively requires to manage the underlying pathological changes as well. Based on international publications and data, it is a frequent condition and more frequent in pediatrics. According to Goodhand et al., iron deficiency is present in more than 60% of children, whereas only 14% of them received oral iron therapy. Compared to adult patients, 22% have iron deficiency, and 48% of them received oral and 41% intravenous iron therapy. Miller et al. also highlighted that among young patients iron deficiency anemia is a frequent condition, as almost 50% of the patients were anemic in their cohort. European Crohn's and Colitis Organisation's statements are clear regarding the diagnosis of iron deficiency anemia, and the iron supplementation as well. Third-generation parenteral iron supplementations seem to be safer and more effective than oral iron pills. Oral iron in many cases cannot replace the iron homeostasis as well; furthermore, it can provoke dysbiosis, which can potentially lead to relapse. As a result, we claim that both oral and parenteral should be used more frequently; furthermore, intravenous iron could replace oral medicines as well in certain cases. Despite the fact that iron deficiency anemia is examined by many aspects, further questions can be raised. Can it imply underlying pathological lesions? Are both oral and intravenous iron therapy safe and effective? When and how are they used? We demand that more studies should be conducted regarding these issues.<\/jats:p>","DOI":"10.3389\/fmed.2021.686778","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:44:50Z","timestamp":1625143490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?"],"prefix":"10.3389","volume":"8","author":[{"given":"Tam\u00e1s","family":"Res\u00e1l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000496728","article-title":"Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease","volume":"142","author":"Jimenez","year":"2019","journal-title":"Acta Haematol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.crohns.2011.12.001","article-title":"Anaemia and iron deficiency in children with inflammatory bowel disease","volume":"6","author":"Wiskin","year":"2012","journal-title":"J Crohns Colitis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3324\/haematol.2009.009985","article-title":"Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment","volume":"95","author":"Bergamaschi","year":"2010","journal-title":"Haematologica"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1097\/MIB.0000000000000191","article-title":"Anemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients","volume":"20","author":"Sj\u00f6berg","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/apt.14920","article-title":"Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study","volume":"48","author":"Eriksson","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2450\/2016.0246-15","article-title":"High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life","volume":"14","author":"Garc\u00eda-L\u00f3pez","year":"2016","journal-title":"Blood Transfus."},{"key":"B7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4291\/wjgp.v6.i3.62","article-title":"Iron deficiency anemia in inflammatory bowel disease","volume":"6","author":"Kaitha","year":"2015","journal-title":"World J Gastrointest Pathophysiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/S0272-6386(99)70150-2","article-title":"Normalizing hematocrit in dialysis patients improves brain function","volume":"33","author":"Pickett","year":"1999","journal-title":"Am J Kidney Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/joim.13004","article-title":"Iron deficiency anaemia revisited","volume":"287","author":"Cappellini","year":"2020","journal-title":"J Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.mcna.2016.09.004","article-title":"Iron deficiency anemia","volume":"101","author":"DeLoughery","year":"2017","journal-title":"Med Clin North Am."},{"key":"B11","doi-asserted-by":"publisher","first-page":"582163","DOI":"10.1155\/2015\/582163","article-title":"The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency","volume":"2015","author":"\u00c7eki\u00e7","year":"2015","journal-title":"Gastroenterol Res Pract."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.178","article-title":"The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure","volume":"205","author":"Ebner","year":"2016","journal-title":"Int J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.amjsurg.2017.02.016","article-title":"Preoperative anemia and outcomes in patients undergoing surgery for inflammatory bowel disease","volume":"215","author":"Michailidou","year":"2018","journal-title":"Am J Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.3748\/wjg.15.4659","article-title":"Anemia and inflammatory bowel diseases","volume":"15","author":"Gomoll\u00f3n","year":"2009","journal-title":"World J Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/01.mib.0000235097.86360.04","article-title":"Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation","volume":"12","author":"Semrin","year":"2006","journal-title":"Inflamm Bowel Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3324\/haematol.2009.017046","article-title":"Pathogenesis and treatment of anemia in inflammatory bowel disease","volume":"95","author":"Weiss","year":"2010","journal-title":"Haematologica."},{"key":"B17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5114\/pg.2014.45102","article-title":"The role of hepcidin, ferroportin, HCP1, and DMT1 protein in iron absorption in the human digestive tract","volume":"9","author":"Przybyszewska","year":"2014","journal-title":"Prz Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J Crohns Colitis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ibd.21740","article-title":"Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease","volume":"18","author":"Goodhand","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/nu10010082","article-title":"Rational management of iron-deficiency anaemia in inflammatory bowel disease","volume":"10","author":"Nielsen","year":"2018","journal-title":"Nutrients."},{"key":"B22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/17474086.2017.1355233","article-title":"Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease","volume":"10","author":"Bou-Fakhredin","year":"2017","journal-title":"Exp Rev Hematol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/gutjnl-2015-309940","article-title":"Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD","volume":"66","author":"Lee","year":"2017","journal-title":"Gut."},{"key":"B24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s15006-013-0732-4","article-title":"Bedeutung der verschiedenen i.v.-Eisengenerationen f\u00fcr den medizinischen alltag [Importance of the different i.v. iron generations for everyday medical practice]","volume":"155","author":"Biggar","year":"2013","journal-title":"MMW Fortschr Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ajh.20056","article-title":"Parenteral iron therapy options","volume":"76","author":"Silverstein","year":"2004","journal-title":"Am J Hematol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.686778\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:44:51Z","timestamp":1625143491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.686778\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":25,"alternative-id":["10.3389\/fmed.2021.686778"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.686778","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"686778"}}